Dariohealth announces preliminary fourth quarter and full year 2022 operating results

Preliminary results demonstrate success in b2c to b2b transformation total revenue for the year is expected to be $27.5 million compared to $20.5 million in 2021. b2b expected to represent approximately 60% of revenue in 2022 versus 4% in 2021 continued improvement of company's financial profile, reducing its operating loss by more than 50% compared to the fourth quarter of 2021.
DRIO Ratings Summary
DRIO Quant Ranking